| Autor: |
Okumura K; Division of Experimental Animal Research, Cancer Genome Center, Chiba Cancer Center Research Institute, Chiba, Japan., Morinaga T; Division of Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan., Saito M; Division of Experimental Animal Research, Cancer Genome Center, Chiba Cancer Center Research Institute, Chiba, Japan., Tokunaga Y; Division of Experimental Animal Research, Cancer Genome Center, Chiba Cancer Center Research Institute, Chiba, Japan., Otoyama K; Division of Experimental Animal Research, Cancer Genome Center, Chiba Cancer Center Research Institute, Chiba, Japan., Tanaka S; Division of Experimental Animal Research, Cancer Genome Center, Chiba Cancer Center Research Institute, Chiba, Japan., Isogai E; Division of Experimental Animal Research, Cancer Genome Center, Chiba Cancer Center Research Institute, Chiba, Japan., Kawazu M; Division of Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan., Togashi Y; Division of Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan; Department of Tumor Microenvironment, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan., Araki K; Division of Developmental Genetics, Institute of Resource Development and Analysis, Kumamoto University, Chuouku, Japan., Wakabayashi Y; Division of Experimental Animal Research, Cancer Genome Center, Chiba Cancer Center Research Institute, Chiba, Japan. Electronic address: yuichi_wakabayashi@chiba-cc.jp. |
